Industry News
Pharmaceutical Industry News
Amid BeiGene’s global expansion push, CEO Oyler scores 16% pay raise to $16.7M
Amid BeiGene's global expansion push, CEO Oyler scores 16% pay raise to $16.7M kdunleavy Thu, 05/05/2022 - 09:11
Philip Morris recruits FDA vet as part of its move away from cigarettes
Philip Morris recruits FDA vet as part of its move away from cigarettes jkeenan Thu, 05/05/2022 - 08:57
AZ’s Farxiga nabs heart failure win in bid to catch up to Lilly, Boehringer’s Jardiance
AZ's Farxiga nabs heart failure win in bid to catch up to Lilly, Boehringer's Jardiance fkansteiner Thu, 05/05/2022 - 08:50
Thermo Fisher, Charles River join robotics outfit Multiply Labs’ quest to automate cell therapy production
Thermo Fisher, Charles River join robotics outfit Multiply Labs' quest to automate cell therapy production fkansteiner Thu, 05/05/2022 - 07:45
Move over, Roche: AstraZeneca and Daiichi’s Enhertu snags FDA nod for earlier breast cancer use
Move over, Roche: AstraZeneca and Daiichi's Enhertu snags FDA nod for earlier breast cancer use aliu Thu, 05/05/2022 - 05:57
FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return
FDA rebukes Pfizer CEO’s suggestion to take more Paxlovid if COVID-19 symptoms return zbecker Wed, 05/04/2022 - 15:29
Prostate Cancer: Janssen’s Commitment to Patients Begins with Science
Prostate Cancer: Janssen’s Commitment to Patients Begins with Science cbilt Wed, 05/04/2022 - 13:47
Takeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusion
Takeda spinout Phathom clinches FDA twin nods for GI infection combos—plus timely capital infusion aliu Wed, 05/04/2022 - 11:21
Amarin, after 33% revenue decline, aims to ‘stabilize’ US sales and grow in Europe
Amarin, after 33% revenue decline, aims to 'stabilize' US sales and grow in Europe zbecker Wed, 05/04/2022 - 11:16
Regeneron counts on Eylea’s track record to fend off Roche rival Vabysmo
Regeneron counts on Eylea's track record to fend off Roche rival Vabysmo kdunleavy Wed, 05/04/2022 - 11:07
Moderna tunes booster pitch ahead of potential shift to private COVID vaccine market this fall
Moderna tunes booster pitch ahead of potential shift to private COVID vaccine market this fall fkansteiner Wed, 05/04/2022 - 10:10
‘The Top Line’ podcast: Biogen’s overhaul reaches CEO level; the most influential people in biopharma; plus this week’s headlines
'The Top Line' podcast: Biogen's overhaul reaches CEO level; the most influential people in biopharma; plus this week's headlines tcarey Wed, 05/04/2022 - 10:10
Next Biogen CEO’s most-prized expertise? Dealmaking experience, investors say
Next Biogen CEO's most-prized expertise? Dealmaking experience, investors say aliu Wed, 05/04/2022 - 09:30
Dupixent makers Sanofi, Regeneron want you to ‘Du More’ in latest asthma DTC campaign
Dupixent makers Sanofi, Regeneron want you to 'Du More' in latest asthma DTC campaign badams Wed, 05/04/2022 - 06:03
Teva cuts sales guidance amid competitive pressures, currency exchange woes
Teva cuts sales guidance amid competitive pressures, currency exchange woes zbecker Tue, 05/03/2022 - 16:03
Bayer’s Nubeqa one step closer to blockbuster status thanks to FDA priority review in potential new use
Bayer's Nubeqa one step closer to blockbuster status thanks to FDA priority review in potential new use kdunleavy Tue, 05/03/2022 - 15:40
Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm
The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefits and serious safety risks.
Deadly Venom From Spiders and Snakes May Cure What Ails You
Efforts to tease apart the vast swarm of proteins in venom — a field called venomics — have burgeoned in recent years, leading to important drug discoveries.
Pfizer sticks to guns on $22B Paxlovid sales despite reports of lagging demand
Pfizer sticks to guns on $22B Paxlovid sales despite reports of lagging demand fkansteiner Tue, 05/03/2022 - 11:35
Incyte says it has added 2nd manufacturing site to remedy Opzelura production problems
Incyte says it has added 2nd manufacturing site to remedy Opzelura production problems kdunleavy Tue, 05/03/2022 - 10:56